On ECHEMI
Home > Drugs > Bortezomib Registered Holders
Bortezomib structure

Bortezomib structure

Bortezomib

Yellow SolidChEBI: L-Phenylalaninamide substituted at the amide nitrogen by a 1-(dihydroxyboranyl)-3-methylbutyl group and at Nalpha by a pyrazin-2-ylcarbonyl group. It is a dipeptidyl boronic acid tha reversibly inhibits the 26S proteasome.Bortezomib, a modified dipeptidyl boronic acid, is a therapeutic proteasome inhibitors used for the treatment of cancers. It is indicated for the treatment of relapsed multiple myeloma and mantle cell lymphoma. It is capable of inhibiting the mammalian 26S

Find 52 Related Holders

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Japan Japan

API Registration Country

API Active
GLAND CHEMICALS PRIVATE LTD
United States United States

API Registration Country

API Active
HUBEI HONCH PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
SEACROSS PHARMA USA INC
United States United States

API Registration Country

API Active
ARTHUR GROUP LLC
United States United States

API Registration Country

API Active
Sun Pharmaceutical Industries Ltd
United States United States

API Registration Country

API Active
HAINAN SHUANGCHENG PHARMACEUTICALS CO LTD
United States United States

API Registration Country

API Active
SHIVALIK RASAYAN LTD
United States United States

API Registration Country

API Active
ScinoPharm Taiwan Ltd
United States United States

API Registration Country

API Active
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
United States United States

API Registration Country

API Active
Recommended Suppliers of Bortezomib
View 196 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.